Medicine Prices
-
{
- All
- News
- Videos
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
- Friday April 3, 2026
- World News | Edited by Srishti Kapoor
The bigger picture threatens a move away from established production hubs like India.
-
www.ndtv.com
-
Doctor Sounds Alarm on 'Predatory Pricing' In Private Hospitals: "Rs 64,000 For 3-Day Treatment"
- Sunday March 29, 2026
- Feature | Edited by Ritu Singh
The doctor criticised corporate hospital chains for acting as a "financial sinkhole" by inflating medicine prices and prescribing redundant tests.
-
www.ndtv.com
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
- Thursday March 26, 2026
- India News | NDTV
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
www.ndtv.com
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
- Monday March 23, 2026
- Health | Written by Shreya Goswami
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
www.ndtv.com
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
- Saturday March 21, 2026
- Feature | Edited by Nikhil Pandey
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
www.ndtv.com
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
- Sunday March 22, 2026
- Health | Written by Dr Kona Lakshmi Kumari
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
www.ndtv.com
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
- Friday March 20, 2026
- Health | Written by Dr Hari Kishan Boorugu
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
www.ndtv.com
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
- Friday March 20, 2026
- Health | Indo-Asian News Service
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
- Friday April 3, 2026
- World News | Edited by Srishti Kapoor
The bigger picture threatens a move away from established production hubs like India.
-
www.ndtv.com
-
Doctor Sounds Alarm on 'Predatory Pricing' In Private Hospitals: "Rs 64,000 For 3-Day Treatment"
- Sunday March 29, 2026
- Feature | Edited by Ritu Singh
The doctor criticised corporate hospital chains for acting as a "financial sinkhole" by inflating medicine prices and prescribing redundant tests.
-
www.ndtv.com
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
- Thursday March 26, 2026
- India News | NDTV
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
www.ndtv.com
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
- Monday March 23, 2026
- Health | Written by Shreya Goswami
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
www.ndtv.com
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
- Saturday March 21, 2026
- Feature | Edited by Nikhil Pandey
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
www.ndtv.com
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
- Sunday March 22, 2026
- Health | Written by Dr Kona Lakshmi Kumari
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
www.ndtv.com
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
- Friday March 20, 2026
- Health | Written by Dr Hari Kishan Boorugu
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
www.ndtv.com
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
- Friday March 20, 2026
- Health | Indo-Asian News Service
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com